Molecular mechanisms of anticancer activity of natural dietetic products

Journal of Molecular Medicine

Volumn 78, Issue 6, 2000, Pages 333-336

  Colic, M ^a   Pavelic, K ^b  

^a Molecutec Corporation   (United States)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Dietetic supplements; Mechanism of anticancer activity

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BAICALIN; CATECHIN; FLAVONOID; FLAVOPIRIDOL; NATURAL PRODUCT; PLANT EXTRACT; POLYPHENOL; PYRROLIDINE DITHIOCARBAMATE; SCAVENGER; XIAO CHAI HU TANG; ZEOLITE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETETICS; DRUG RESEARCH; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SOYBEAN; TEA;

EID: 0033865492     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000121     Document Type: Review

References (23)

1. Health-regulation of 'nutraceuticals'
2. Alternative medicine-beefed-up NIH center probes unconventional therapies
3. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer-a p53-independent induction of p21 (WAF1/CIP1) via c/ebp-beta
4. Antioxidant-induced nuclear translation of CCAAT/enhancer-binding protein beta-critical role for protein kinase A-mediated phosphorylation of SER (299)
5. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G (1) phase arrest in A549 lung adenocarcinoma cells
6. Genistein induces p21 (CIP1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells
7. Modulation of cancer chemotherapy by green tea
8. Inhibition of cyclin-dependent kinase 2 and 4 activities as well as induction of CDK inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-) epigallocatechin - 3-gallate
9. Flavopiridol induces G (1) arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells
10. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase
11. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
12. The JUN kinase stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
13. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
14. p21WAF1 Is dynamically associated with JNK in human T-lymphocytes during cell cycle progression
15. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172)
16. The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating fos-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases
17. Angiogenesis inhibited by drinking tea
18. Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: Presentation of a novel therapeutic paradigm
19. Preclinical and clinical development of cyclin-dependent kinase modulators
20. A phase II trial of flavopiridol in patients with stage IV non-small cell lung cancer
21. Histone acetylation and cancer
22. An information-intensive approach to the molecular pharmacology of cancer